---
$id: https://graph.org.ai/products/commodity/51332814
$type: Product
source: UNSPSC
code: "51332814"
title: "Levomepromazine or methotrimeprazine"
class: "51332800"
classTitle: "Antipsychotic phenothiazines"
family: "51330000"
familyTitle: "Antipsychotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Levomepromazine or methotrimeprazine

**UNSPSC Code**: 51332814
**Class**: [Antipsychotic phenothiazines](Antipsychotic phenothiazines.mdx)
**Family**: [Antipsychotics](../Antipsychotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a phenothiazine with the molecular formula C19H24N2OS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9G0LAW7ATQ, chemically known as 10h-phenothiazine-10-propanamine, 2-methoxy-n,n,beta-trimethyl-, (r)- but generally known as levomepromazine, which bears US NIH Compound Identifier 3916. European Medicines Agency schedules Levomepromazine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08476MIG. The term LEVOMEPROMAZINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 16, No. 3 1962, List 4). World Health Organization schedules levomepromazine in its Anatomical Therapeutic Chemical (ATC) Classification. LEVOMEPROMAZINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Levomepromazine or methotrimeprazine bears US NLM identifiers UMLS ID C0025678 and NCI Concept Code C66118. SMILES: S1C2C(N(CC(CN(C)C)C)C3C1CCCC3)CC(OC)CC2.

